LOXL3 and melanoma: After adjusting for potential confounders using multivariate Cox regression analysis, Zhang et al. (2021) further confirmed that LOXL3 gene expression is an independent predictor of survival and remains a significant prognostic factor in a cohort of primary melanoma patients.